Management of severe cutaneous adverse drug reactions: what we still have to learn?

被引：0
|
作者：
Tanno, L. K. [1 ]
Tacco, M. C. [1 ]
Camporez, A. [1 ]
Fernandes, F. [1 ]
Pereira, V. A. [1 ]
Aun, W. T. [1 ]
Mello, J. F. [1 ]
机构：
[1] Hosp Serv Publ Estadual Sao Paulo, Sao Paulo, Brazil
来源：
ALLERGY | 2013年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：143 / 143
页数：1
相关论文
共 50 条
  • [1] Management of severe cutaneous adverse drug reactions to corticosteroids
    Waton, J.
    Baeck, M.
    Torres, M.
    Barbaud, A.
    REVUE FRANCAISE D ALLERGOLOGIE, 2013, 53 (03): : 298 - 303
  • [2] Plerixafor: what we still have to learn
    Lanza, Francesco
    Gardellini, Angelo
    Laszlo, Daniele
    Martino, Massimo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (02) : 143 - 147
  • [3] What Have We Learnt From Chernobyl? What Have We Still To Learn?
    Thomas, G. A.
    Tronko, M. D.
    Tsyb, A. F.
    Tuttle, R. M.
    CLINICAL ONCOLOGY, 2011, 23 (04) : 229 - 233
  • [4] Ethical considerations in the management of drug severe cutaneous adverse reactions
    Buckey, Timothy M.
    Ferreira, Alana L.
    Grant-Kels, Jane M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (04) : 964 - 965
  • [5] Severe cutaneous adverse drug reactions
    Chung, Wen-Hung
    Wang, Chuang-Wei
    Dao, Ro-Lan
    JOURNAL OF DERMATOLOGY, 2016, 43 (07): : 758 - 766
  • [6] Severe Cutaneous Adverse Drug Reactions
    Schroeder, J.
    DRUG SAFETY, 2013, 36 (09) : 942 - 942
  • [7] MicroRNAs and cancer: what we know and what we still have to learn
    George A Calin
    Genome Medicine, 1
  • [8] MicroRNAs and cancer: what we know and what we still have to learn
    Calin, George A.
    GENOME MEDICINE, 2009, 1
  • [9] What we have learnt and what we still have to learn from the PREDIMED study
    Estruch, Ramon
    AVANCES EN DIABETOLOGIA, 2013, 29 (04): : 81 - 87
  • [10] Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management
    S. Shahzad Mustafa
    David Ostrov
    Daniel Yerly
    Current Allergy and Asthma Reports, 2018, 18
12345